Business
Herborium® Announces Crypto Currency Capabilities. Expands Revenue and Partnerships Potential. .
Herborium® Announces Crypto Currency Capabilities. Expands Revenue and Partnerships Potential. ..
About this update from Herborium Group, Inc.
[{"type":"text","content":"\n Houston, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Houston, Texas, 11/18/2021. Herborium Group, Inc.  (OTC Pink: HBRM),  a Botanical Therapeutics Company and the provider of unique, all botanical medicinal products with a strong records of efficacy and safety, (Botanical Therapeutics®), and personalized, interactive, medical needs driven content, announced today its capabilities to support the Crypto currency transactions with Bitcoin being the first one to be accepted By supporting the use of Crypto-Currency Herborium joins a very diversified and growing number of American and international companies including Microsoft, AT&T, Burger King , Overstock, Gap, JC Penny and Norwegian Air to name just the few that either directly or indirectly use Bitcoin to facilitate their financial transactions. Herborium intends to embrace both, the Bitcoin credit card and potentially other types of Crypto Currency transactions to generate additional revenues, to be prepared for forthcoming international expansion and to facilitate potential partnerships with others forwards looking businesses. Herborium’s core business model utilizes digital and internet based technologies to enrich and expand its customer base, the use of Crypto Currency is therefore a natural step and directly supports future growth. Today–it is possible to buy almost everything with Bitcoin and the further rise of Bitcoin and other digital currencies is both imminent and accelerating. By accepting Crypto-Currency the company is not only staying current with advances in business executions but also positions Herborium for additional revenues generating capabilities, while at the same time expanding its international presence and attracting global partners. . About Herborium Group, Inc. Herborium Group, Inc., a botanical therapeutics company that develops, license and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products to establish ...